Brodalumab Subcutaneous and Topiramate Extended-Release Capsules
Determining the interaction of Brodalumab Subcutaneous and Topiramate Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: topiramate
Brand name: Qudexy XR Sprinkle, Topamax, Topamax Sprinkle, Trokendi XR, Topiragen, Qudexy XR
Synonyms: Topiramate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Topiramate Extended-Release Sprinkle Capsules
- Brodalumab Subcutaneous-Topiramate Sprinkle Capsules
- Brodalumab Subcutaneous-Topiramate Tablets
- Brodalumab Subcutaneous-Topisulf Cream
- Brodalumab Subcutaneous-Toposar
- Brodalumab Subcutaneous-Toposar injection
- Topiramate Extended-Release Capsules-Brodspec
- Topiramate Extended-Release Capsules-Brom Mal Phenyl HCl Dex HBr
- Topiramate Extended-Release Capsules-Bromaline
- Topiramate Extended-Release Capsules-Bromaline DM
- Topiramate Extended-Release Capsules-Bromatan Plus
- Topiramate Extended-Release Capsules-Bromatan-DM